Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
For patients who started with higher baseline cardiovascular risk, the benefit was even more pronounced (p=0.038)
2.5 mg dose in a 12 mg vial: Target 50 units (0.5 mL)
Injecting B12 on top of a deficiency that has never been investigated can mask the underlying cause and delay a proper diagnosis, such as pernicious anaemia
The clinical trial protocol uses fixed doses (2mg, 4mg, 8mg, 12mg) regardless of body weight
Apply to become an affiliate FOXO4-DRI shipped to research hubs worldwide Same HPLC-verified FOXO4-DRI batch, same COA tracked delivery to laboratories and independent researchers across Europe, the UK, the USA and beyond
US$ 27.89
US$ 20.23
US$ 24.72
US$ 27.75
